You have 9 free searches left this month | for more free features.

Hepatitis C Genotype 1a

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Zepatier in Patients With Substance Use

Active, not recruiting
  • Hepatitis C
  • +3 more
  • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
  • Chicago, Illinois
    University of Illinois at Chicago
Jun 28, 2022

Hepatitis C Infection, HIV Infection Trial in Washington, Bethesda (Nitazoxanide With Pegylated Interferon And Ribavirin)

Completed
  • Hepatitis C Infection
  • HIV Infection
  • Nitazoxanide With Pegylated Interferon And Ribavirin
  • Washington, District of Columbia
  • +3 more
Sep 14, 2021

Chronic Hepatitis C Trial in Baltimore (CDI-31244, SOF/VEL)

Completed
  • Chronic Hepatitis C
  • Baltimore, Maryland
    Institute of Human Virology University of Maryland
Apr 26, 2021

HIV Infection, Hepatitis C Infection Trial in Puerto Rico, United States (Nitazoxanide (NTZ), Pegylated interferon alfa-2a

Completed
  • HIV Infection
  • Hepatitis C Infection
  • Nitazoxanide (NTZ)
  • +2 more
  • Birmingham, Alabama
  • +17 more
Nov 2, 2021

Hepatitis C, Chronic Trial in United States (ombitasvir, paritaprevir/r, dasabuvir + ribavirin, ombitasvir, paritaprevir/r,

Completed
  • Hepatitis C, Chronic
  • ombitasvir, paritaprevir/r, dasabuvir + ribavirin
  • ombitasvir, paritaprevir/r, dasabuvir
  • Irvine, California
  • +3 more
Jan 21, 2021

Chronic Hepatitis C Trial (Danoprevir, Ritonavir, peginterferon alfa-2a)

Completed
  • Chronic Hepatitis C
  • (no location specified)
Feb 28, 2021

HIV, Hepatitis C Trial in Puerto Rico, United States (Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT), Dasabuvir (DSV), Ribavirin

Terminated
  • HIV Infections
  • Hepatitis C
  • Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT)
  • +2 more
  • Birmingham, Alabama
  • +15 more
Nov 2, 2021

Hepatitis C Infection Trial (Grazoprevir + Elbasvir, Ribavirin)

Completed
  • Hepatitis C Infection
  • (no location specified)
Jan 15, 2021

Hepatitis C, HCV Trial in San Antonio (TD-6450, Placebo)

Completed
  • Hepatitis C
  • HCV
  • San Antonio, Texas
    Texas Liver Institute
Jan 15, 2021

Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)

Recruiting
  • Hepatitis C, Chronic
  • P1101 + Ribavirin
  • Chiayi City, Taiwan
  • +7 more
Jun 30, 2022

Hepatitis C Trial in Seoul

Completed
  • Hepatitis C
    • Seoul, Korea, Republic of
      Local Institution
    Jan 6, 2022

    Protease Inhibitors in Chronic Hepatitis C

    Completed
    • Chronic Hepatitis C
      • Graz, Austria
        Department of Internal Medicine, Medical University of Graz
      Jan 11, 2023

      Chronic Hepatitis C Genotype-1 Relapse Trial in Worldwide (NIM811, Placebo BID + SOC)

      Completed
      • Chronic Hepatitis C Genotype-1 Relapse
      • San Diego, California
      • +15 more
      Dec 11, 2020

      Hepatitis C, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)

      Not yet recruiting
      • Hepatitis C
      • +2 more
      • Patient Participation Form
      • (no location specified)
      Mar 3, 2023

      Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV))

      Completed
      • Chronic Hepatitis C Virus
      • Hepatitis C Virus
      • (no location specified)
      Jul 14, 2021

      Seroconversion of Hepatitis c Virus Among CKD on Regular

      Not yet recruiting
      • Hepatitis C Virus
        • (no location specified)
        Oct 25, 2023

        Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)

        Completed
        • Chronic Hepatitis C Virus (HCV) Infection
        • (no location specified)
        Jul 14, 2021

        Hepatitis c and Linkage to Treatment in Hospitals in Colombia

        Not yet recruiting
        • Hepatitis C Virus Infection
        • rapid diagnostic test HCV Ab Plus Rapid test
        • Medellín, Antioquia, Colombia
          Hospital Pablo Tobón Uribe
        Nov 24, 2023

        HCV Trial in Beijing (Ravidasvir, Danoprevir, Ritonavir)

        Completed
        • HCV
        • Beijing, Beijing, China
          Peking University People's hospital
        Jul 25, 2020

        Hepatitis C Virus Trial (ABT-493/ABT-530)

        Completed
        • Hepatitis C Virus
        • (no location specified)
        Jul 9, 2021

        Hepatitis C Diagnosis to Treatment Management

        Enrolling by invitation
        • Hepatitis C
        • Hepatitis C Treatment Alerts in CHORUS™
        • Standard of Care
        • Los Angeles, California
          AIDS Healthcare Foundation
        Feb 2, 2023

        Hepatitis C Screening Alerts

        Enrolling by invitation
        • Hepatitis C
        • Hepatitis C Screening Alerts in CHORUS™
        • Standard of Care
        • Los Angeles, California
          AIDS Healthcare Foundation
        Jan 24, 2023